Literature DB >> 6126640

Antidepressant effects of buprenorphine.

H M Emrich, P Vogt, A Herz, W Kissling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6126640     DOI： 10.1016/s0140-6736(82)90727-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Opioidergic Agents as Antidepressants: Rationale and Promise.

Authors:  Parnika P Saxena; J Alexander Bodkin
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans.

Authors:  Anya K Bershad; Melissa A Miller; Greg J Norman; Harriet de Wit
Journal:  Horm Behav       Date:  2018-04-24       Impact factor: 3.587

3.  The anti-suicidal potential of buprenorphine: a case report.

Authors:  Joan M Striebel; Raj K Kalapatapu
Journal:  Int J Psychiatry Med       Date:  2014       Impact factor: 1.210

4.  Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.

Authors:  N Kabli; T Nguyen; G Balboni; B F O'Dowd; S R George
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

Review 5.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

Authors:  Jeffrey M Witkin; Michael A Statnick; Linda M Rorick-Kehn; John E Pintar; Michael Ansonoff; Yanyun Chen; R Craig Tucker; Roberto Ciccocioppo
Journal:  Pharmacol Ther       Date:  2013-11-01       Impact factor: 12.310

6.  Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Pier Paolo Pani; Matteo Pacini; Francesco Lamanna; Fabio Rugani; Elisa Schiavi; Liliana Dell'osso; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2011-05-15       Impact factor: 3.455

Review 7.  New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.

Authors:  Michael Soyka
Journal:  Subst Abuse Rehabil       Date:  2015-01-06

8.  The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial.

Authors:  Jamshid Ahmadi; Mina Sefidfard Jahromi; Zahra Ehsaei
Journal:  Trials       Date:  2018-08-29       Impact factor: 2.279

9.  Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).

Authors:  John M Zajecka; Arielle D Stanford; Asli Memisoglu; William F Martin; Sanjeev Pathak
Journal:  Neuropsychiatr Dis Treat       Date:  2019-04-04       Impact factor: 2.570

10.  Effects of Buprenorphine on Responses to Emotional Stimuli in Individuals with a Range of Mood Symptomatology.

Authors:  Anya K Bershad; Nicholas A Ruiz; Harriet de Wit
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.